Global Peripheral Interventions Market - 2025 -2033
Global Peripheral Interventions Market: Industry Outlook
The global peripheral interventions market reached US$ 9.41 billion in 2023, with a rise of US$ 10.19 billion in 2024, and is expected to reach US$ 22.26 billion by 2033, growing at a CAGR of 9.2% during the forecast period 2025-2033.
The peripheral interventions space is undergoing a rapid transformation, driven by device innovations and the integration of smart technologies into modern cath labs and hybrid ORs. Next-generation systems now combine advanced imaging compatibility, robotics-assisted navigation, and ultra-low-profile access solutions to deliver higher precision in treating complex vascular conditions. Intelligent peripheral intervention devices, equipped with advanced sensors and connectivity capabilities, enable real-time procedural adjustments tailored to patient-specific hemodynamic data, enhancing both accuracy and safety. At the same time, ergonomically designed delivery systems and catheters provide superior clinician control, minimizing fatigue during complex or lengthy procedures. These advancements are streamlining workflows, shortening procedure times, and improving patient outcomes.
Dynamics: Drivers & Restraints
Driver: Rising Prevalence of Peripheral Artery Disease (PAD) & VTE
The growing prevalence of peripheral artery disease (PAD) and venous thromboembolism (VTE) is a key driver of demand for peripheral interventions, as these conditions are affecting an increasing number of patients worldwide due to aging populations, rising diabetes and obesity rates, sedentary lifestyles, and persistent smoking habits. PAD, characterized by arterial narrowing that restricts blood flow to the limbs, often leads to pain, mobility loss, and in severe cases, amputation. According to Elsevier B.V. in 2025, peripheral artery disease (PAD) prevalence rises with age, roughly doubling every decade, and currently affects about 6.5 million adults (5.8%) aged 40 and above, with an annual incidence rate of 2.69%. The global increase in PAD cases elevates the risk of complications, resulting in more hospitalizations and interventions.
Similarly, VTE, encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), remains a leading cause of cardiovascular-related morbidity and mortality, necessitating rapid and effective interventional management. These epidemiological trends are pushing healthcare systems to adopt advanced minimally invasive solutions that not only restore circulation but also reduce recovery times, prevent recurrence, and improve long-term outcomes, thereby fueling consistent growth in the peripheral interventions sector.
Restraint: High Device Costs and Procedure Expenses
High device costs and overall procedure expenses are expected to restrain the growth of the peripheral interventions market, particularly in low- and middle-income regions where healthcare budgets are limited. Advanced devices such as drug-eluting stents, atherectomy systems, and intravascular imaging tools often come with premium pricing, while associated costs for specialized staff, hybrid operating rooms, and post-procedure care further increase the financial burden. These factors can limit accessibility for patients, delay adoption in smaller healthcare facilities, and place pressure on reimbursement systems, ultimately slowing market penetration despite the clinical benefits of these technologies.
Segmentation Analysis
The global peripheral interventions market is segmented based on product type, intervention type, application, end-user, and region.
Product Type:
The stents segment is estimated to have 24.8% of the Peripheral Interventions market share.
The stents segment is expected to dominate the peripheral interventions market, driven by continuous advancements in stent technology and their critical role in restoring and maintaining vessel patency in patients with peripheral artery disease (PAD). Modern stents, including drug-eluting stents (DES), covered stents, and bioresorbable scaffolds, offer improved deliverability, radial strength, and biocompatibility, reducing restenosis rates and the need for repeat procedures.
Innovations such as flexible designs for tortuous anatomies, enhanced coatings for drug delivery, and compatibility with smaller-diameter delivery systems are expanding treatment options for complex lesions in femoro-popliteal, iliac, and below-the-knee arteries. For instance, in April 2024, Abbott announced FDA approval of the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a cutting-edge solution for patients with chronic limb-threatening ischemia (CLTI) below the knee. The Esprit BTK System is engineered to maintain arterial patency and deliver Everolimus to aid vessel healing before fully resorbing, offering a minimally invasive approach to improve patient outcomes. Additionally, the growing adoption of minimally invasive endovascular procedures, favorable clinical outcomes, and increasing global PAD prevalence are reinforcing the stent segment’s leadership position within the peripheral interventions market.
Geographical Share Analysis
The North America peripheral interventions market was valued at 41.2% market share in 2024
North America holds a dominant position in the peripheral interventions market, supported by a combination of advanced healthcare infrastructure, high adoption of cutting-edge endovascular technologies, and the strong presence of leading medical device manufacturers. The region faces a significant burden of peripheral artery disease (PAD) and venous thromboembolism (VTE), driven by aging populations, high obesity and diabetes rates, and lifestyle-related risk factors such as smoking and sedentary habits. Favorable reimbursement policies, robust physician training programs, and widespread availability of specialized vascular centers further accelerate the uptake of innovative devices, including drug-coated balloons, atherectomy systems, stents, and intravascular imaging tools.
Continuous R&D investment, frequent FDA approvals, and early adoption of minimally invasive techniques also position North America at the forefront of market growth, making it a hub for both technological innovation and high procedural volumes in peripheral interventions. For instance, in March 2023, Shockwave Medical, Inc. announced the full U.S. commercial launch of the Shockwave L6 Peripheral IVL Catheter following FDA clearance. The L6 catheter is specifically designed to treat challenging calcified lesions in large peripheral vessels, including the iliac and common femoral arteries, enhancing procedural effectiveness and patient outcomes.
Major Players
The major players in the peripheral interventions market include Boston Scientific Corporation, Medtronic, Abbott, Terumo Corporation, Cook, B. Braun SE, BD, Cordis, Biotronik, and W. L. Gore & Associates, Inc., among others.
Key Developments
The global peripheral interventions market reached US$ 9.41 billion in 2023, with a rise of US$ 10.19 billion in 2024, and is expected to reach US$ 22.26 billion by 2033, growing at a CAGR of 9.2% during the forecast period 2025-2033.
The peripheral interventions space is undergoing a rapid transformation, driven by device innovations and the integration of smart technologies into modern cath labs and hybrid ORs. Next-generation systems now combine advanced imaging compatibility, robotics-assisted navigation, and ultra-low-profile access solutions to deliver higher precision in treating complex vascular conditions. Intelligent peripheral intervention devices, equipped with advanced sensors and connectivity capabilities, enable real-time procedural adjustments tailored to patient-specific hemodynamic data, enhancing both accuracy and safety. At the same time, ergonomically designed delivery systems and catheters provide superior clinician control, minimizing fatigue during complex or lengthy procedures. These advancements are streamlining workflows, shortening procedure times, and improving patient outcomes.
Dynamics: Drivers & Restraints
Driver: Rising Prevalence of Peripheral Artery Disease (PAD) & VTE
The growing prevalence of peripheral artery disease (PAD) and venous thromboembolism (VTE) is a key driver of demand for peripheral interventions, as these conditions are affecting an increasing number of patients worldwide due to aging populations, rising diabetes and obesity rates, sedentary lifestyles, and persistent smoking habits. PAD, characterized by arterial narrowing that restricts blood flow to the limbs, often leads to pain, mobility loss, and in severe cases, amputation. According to Elsevier B.V. in 2025, peripheral artery disease (PAD) prevalence rises with age, roughly doubling every decade, and currently affects about 6.5 million adults (5.8%) aged 40 and above, with an annual incidence rate of 2.69%. The global increase in PAD cases elevates the risk of complications, resulting in more hospitalizations and interventions.
Similarly, VTE, encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), remains a leading cause of cardiovascular-related morbidity and mortality, necessitating rapid and effective interventional management. These epidemiological trends are pushing healthcare systems to adopt advanced minimally invasive solutions that not only restore circulation but also reduce recovery times, prevent recurrence, and improve long-term outcomes, thereby fueling consistent growth in the peripheral interventions sector.
Restraint: High Device Costs and Procedure Expenses
High device costs and overall procedure expenses are expected to restrain the growth of the peripheral interventions market, particularly in low- and middle-income regions where healthcare budgets are limited. Advanced devices such as drug-eluting stents, atherectomy systems, and intravascular imaging tools often come with premium pricing, while associated costs for specialized staff, hybrid operating rooms, and post-procedure care further increase the financial burden. These factors can limit accessibility for patients, delay adoption in smaller healthcare facilities, and place pressure on reimbursement systems, ultimately slowing market penetration despite the clinical benefits of these technologies.
Segmentation Analysis
The global peripheral interventions market is segmented based on product type, intervention type, application, end-user, and region.
Product Type:
The stents segment is estimated to have 24.8% of the Peripheral Interventions market share.
The stents segment is expected to dominate the peripheral interventions market, driven by continuous advancements in stent technology and their critical role in restoring and maintaining vessel patency in patients with peripheral artery disease (PAD). Modern stents, including drug-eluting stents (DES), covered stents, and bioresorbable scaffolds, offer improved deliverability, radial strength, and biocompatibility, reducing restenosis rates and the need for repeat procedures.
Innovations such as flexible designs for tortuous anatomies, enhanced coatings for drug delivery, and compatibility with smaller-diameter delivery systems are expanding treatment options for complex lesions in femoro-popliteal, iliac, and below-the-knee arteries. For instance, in April 2024, Abbott announced FDA approval of the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a cutting-edge solution for patients with chronic limb-threatening ischemia (CLTI) below the knee. The Esprit BTK System is engineered to maintain arterial patency and deliver Everolimus to aid vessel healing before fully resorbing, offering a minimally invasive approach to improve patient outcomes. Additionally, the growing adoption of minimally invasive endovascular procedures, favorable clinical outcomes, and increasing global PAD prevalence are reinforcing the stent segment’s leadership position within the peripheral interventions market.
Geographical Share Analysis
The North America peripheral interventions market was valued at 41.2% market share in 2024
North America holds a dominant position in the peripheral interventions market, supported by a combination of advanced healthcare infrastructure, high adoption of cutting-edge endovascular technologies, and the strong presence of leading medical device manufacturers. The region faces a significant burden of peripheral artery disease (PAD) and venous thromboembolism (VTE), driven by aging populations, high obesity and diabetes rates, and lifestyle-related risk factors such as smoking and sedentary habits. Favorable reimbursement policies, robust physician training programs, and widespread availability of specialized vascular centers further accelerate the uptake of innovative devices, including drug-coated balloons, atherectomy systems, stents, and intravascular imaging tools.
Continuous R&D investment, frequent FDA approvals, and early adoption of minimally invasive techniques also position North America at the forefront of market growth, making it a hub for both technological innovation and high procedural volumes in peripheral interventions. For instance, in March 2023, Shockwave Medical, Inc. announced the full U.S. commercial launch of the Shockwave L6 Peripheral IVL Catheter following FDA clearance. The L6 catheter is specifically designed to treat challenging calcified lesions in large peripheral vessels, including the iliac and common femoral arteries, enhancing procedural effectiveness and patient outcomes.
Major Players
The major players in the peripheral interventions market include Boston Scientific Corporation, Medtronic, Abbott, Terumo Corporation, Cook, B. Braun SE, BD, Cordis, Biotronik, and W. L. Gore & Associates, Inc., among others.
Key Developments
- In December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, announced the U.S. launch of its R2P NaviCross peripheral support catheter, further strengthening its radial-to-peripheral (R2P) portfolio. The R2P NaviCross is specifically designed to optimize performance in R2P procedures. Featuring a double-braided stainless-steel construction, it offers exceptional trackability and precise torque control, enabling clinicians to navigate and cross lesions effectively in even the most complex peripheral interventions.
- In September 2024, Shockwave Medical, Inc. announced the full U.S. launch of its Shockwave E8 Peripheral IVL Catheter following FDA clearance. The Shockwave E8 is engineered to enhance treatment outcomes for patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including those facing complex chronic limb-threatening ischemia (CLTI).
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Intervention Type
2.5. Snippet by Application
2.6. Snippet by End-User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Peripheral Artery Disease (PAD) & VTE
3.1.1.2. Shift Toward Minimally Invasive Procedures
3.1.2. Restraints
3.1.2.1. High Device Costs and Procedure Expenses
3.1.2.2. Stringent Regulatory Approval Processes
3.1.3. Opportunity
3.1.3.1. High Growth Potential in Emerging Markets
3.1.3.2. Innovation in Bioabsorbable & Next-Gen Materials
3.1.4. Impact Analysis
4. GLOBAL PERIPHERAL INTERVENTIONS MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Stents*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Angioplasty Balloons
5.4. Catheters & Sheaths
5.5. Guide Wires
5.6. Atherectomy Devices
5.7. Embolic / Embolization Devices
5.8. Thrombectomy Devices
5.9. Inferior Vena Cava (IVC) Filters
5.10. Other Devices & Accessories
6. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY INTERVENTION TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
6.1.2. Market Attractiveness Index, By Intervention Type
6.2. Atherectomy*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Stent Implantation
6.4. Angioplasty
6.5. Thrombectomy
6.6. Embolization
7. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Peripheral Artery Disease*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Venous Thromboembolism
7.4. Deep Vein Thrombosis (DVT)
7.5. Others
8. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. ASCs
8.4. Cath Labs/Specialty Clinics
8.5. Other
9. GLOBAL PERIPHERAL INTERVENTIONS MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
10. INTRODUCTION
10.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.1. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking
12. COMPANY PROFILES
12.1. Boston Scientific Corporation*
12.1.1. Company Overview
12.1.1.1. Product Portfolio
12.1.1.2. Product Description
12.1.1.3. Product Key Performance Indicators (KPIs)
12.1.1.4. Historic and Forecasted Product Sales
12.1.1.5. Product Sales Volume
12.1.2. Financial Overview
12.1.2.1. Company Revenue
12.1.2.2. Geographical Revenue Shares
12.1.2.3. Revenue Forecasts
12.1.3. Key Developments
12.1.3.1. Mergers & Acquisitions
12.1.3.2. Key Product Development Activities
12.1.3.3. Regulatory Approvals, etc.
12.1.3.4. SWOT Analysis
12.2. Medtronic
12.3. Abbott
12.4. Terumo Corporation
12.5. Cook
12.6. B. Braun SE
12.7. BD
12.8. Cordis
12.9. Biotronik
12.10. W. L. Gore & Associates, Inc. (LIST NOT EXHAUSTIVE )
13. ASSUMPTIONS AND RESEARCH METHODOLOGY
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Intervention Type
2.5. Snippet by Application
2.6. Snippet by End-User
2.7. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Peripheral Artery Disease (PAD) & VTE
3.1.1.2. Shift Toward Minimally Invasive Procedures
3.1.2. Restraints
3.1.2.1. High Device Costs and Procedure Expenses
3.1.2.2. Stringent Regulatory Approval Processes
3.1.3. Opportunity
3.1.3.1. High Growth Potential in Emerging Markets
3.1.3.2. Innovation in Bioabsorbable & Next-Gen Materials
3.1.4. Impact Analysis
4. GLOBAL PERIPHERAL INTERVENTIONS MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Stents*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Angioplasty Balloons
5.4. Catheters & Sheaths
5.5. Guide Wires
5.6. Atherectomy Devices
5.7. Embolic / Embolization Devices
5.8. Thrombectomy Devices
5.9. Inferior Vena Cava (IVC) Filters
5.10. Other Devices & Accessories
6. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY INTERVENTION TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
6.1.2. Market Attractiveness Index, By Intervention Type
6.2. Atherectomy*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Stent Implantation
6.4. Angioplasty
6.5. Thrombectomy
6.6. Embolization
7. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Peripheral Artery Disease*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Venous Thromboembolism
7.4. Deep Vein Thrombosis (DVT)
7.5. Others
8. GLOBAL PERIPHERAL INTERVENTIONS MARKET: BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. ASCs
8.4. Cath Labs/Specialty Clinics
8.5. Other
9. GLOBAL PERIPHERAL INTERVENTIONS MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
10. INTRODUCTION
10.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.1. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Intervention Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking
12. COMPANY PROFILES
12.1. Boston Scientific Corporation*
12.1.1. Company Overview
12.1.1.1. Product Portfolio
12.1.1.2. Product Description
12.1.1.3. Product Key Performance Indicators (KPIs)
12.1.1.4. Historic and Forecasted Product Sales
12.1.1.5. Product Sales Volume
12.1.2. Financial Overview
12.1.2.1. Company Revenue
12.1.2.2. Geographical Revenue Shares
12.1.2.3. Revenue Forecasts
12.1.3. Key Developments
12.1.3.1. Mergers & Acquisitions
12.1.3.2. Key Product Development Activities
12.1.3.3. Regulatory Approvals, etc.
12.1.3.4. SWOT Analysis
12.2. Medtronic
12.3. Abbott
12.4. Terumo Corporation
12.5. Cook
12.6. B. Braun SE
12.7. BD
12.8. Cordis
12.9. Biotronik
12.10. W. L. Gore & Associates, Inc. (LIST NOT EXHAUSTIVE )
13. ASSUMPTIONS AND RESEARCH METHODOLOGY
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
LIST OF TABLES
Table 1 Global Peripheral Interventions Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Peripheral Interventions Market Value, By Intervention Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Peripheral Interventions Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Peripheral Interventions Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Peripheral Interventions Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Peripheral Interventions Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Peripheral Interventions Market Value, By Intervention Type, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 10 Global Peripheral Interventions Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Peripheral Interventions Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 14 Global Peripheral Interventions Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Peripheral Interventions Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 18 North America Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 North America Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Europe Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 28 Europe Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Europe Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Europe Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 South America Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 33 South America Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 35 South America Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Boston Scientific Corporation: Overview
Table 42 Boston Scientific Corporation: Product Portfolio
Table 43 Boston Scientific Corporation: Key Developments
Table 44 Medtronic: Overview
Table 45 Medtronic: Product Portfolio
Table 46 Medtronic: Key Developments
Table 47 Abbott: Overview
Table 48 Abbott: Product Portfolio
Table 49 Abbott: Key Developments
Table 50 Terumo Corporation: Overview
Table 51 Terumo Corporation: Product Portfolio
Table 52 Terumo Corporation: Key Developments
Table 53 Cook: Overview
Table 54 Cook: Product Portfolio
Table 55 Cook: Key Developments
Table 56 B. Braun SE: Overview
Table 57 B. Braun SE: Product Portfolio
Table 58 B. Braun SE: Key Developments
Table 59 BD: Overview
Table 60 BD: Product Portfolio
Table 61 BD: Key Developments
Table 62 Cordis: Overview
Table 63 Cordis: Product Portfolio
Table 64 Cordis: Key Developments
Table 65 Biotronik: Overview
Table 66 Biotronik: Product Portfolio
Table 67 Biotronik: Key Developments
Table 68 W. L. Gore & Associates, Inc.: Overview
Table 69 W. L. Gore & Associates, Inc.: Product Portfolio
Table 70 W. L. Gore & Associates, Inc.: Key Developments
Table 1 Global Peripheral Interventions Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Peripheral Interventions Market Value, By Intervention Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Peripheral Interventions Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Peripheral Interventions Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Peripheral Interventions Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Peripheral Interventions Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 7 Global Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 8 Global Peripheral Interventions Market Value, By Intervention Type, 2025, 2029 & 2033 (US$ Billion)
Table 9 Global Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 10 Global Peripheral Interventions Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 11 Global Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 12 Global Peripheral Interventions Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 13 Global Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 14 Global Peripheral Interventions Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 15 Global Peripheral Interventions Market Value, By Region, 2022-2033 (US$ Billion)
Table 16 North America Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 17 North America Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 18 North America Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 North America Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 North America Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Asia-Pacific Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Asia-Pacific Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 23 Asia-Pacific Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 24 Asia-Pacific Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 26 Europe Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 27 Europe Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 28 Europe Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 29 Europe Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 30 Europe Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 31 South America Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 32 South America Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 33 South America Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 34 South America Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 35 South America Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 36 Middle East and Africa Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 37 Middle East and Africa Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)
Table 38 Middle East and Africa Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)
Table 39 Middle East and Africa Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)
Table 40 Middle East and Africa Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)
Table 41 Boston Scientific Corporation: Overview
Table 42 Boston Scientific Corporation: Product Portfolio
Table 43 Boston Scientific Corporation: Key Developments
Table 44 Medtronic: Overview
Table 45 Medtronic: Product Portfolio
Table 46 Medtronic: Key Developments
Table 47 Abbott: Overview
Table 48 Abbott: Product Portfolio
Table 49 Abbott: Key Developments
Table 50 Terumo Corporation: Overview
Table 51 Terumo Corporation: Product Portfolio
Table 52 Terumo Corporation: Key Developments
Table 53 Cook: Overview
Table 54 Cook: Product Portfolio
Table 55 Cook: Key Developments
Table 56 B. Braun SE: Overview
Table 57 B. Braun SE: Product Portfolio
Table 58 B. Braun SE: Key Developments
Table 59 BD: Overview
Table 60 BD: Product Portfolio
Table 61 BD: Key Developments
Table 62 Cordis: Overview
Table 63 Cordis: Product Portfolio
Table 64 Cordis: Key Developments
Table 65 Biotronik: Overview
Table 66 Biotronik: Product Portfolio
Table 67 Biotronik: Key Developments
Table 68 W. L. Gore & Associates, Inc.: Overview
Table 69 W. L. Gore & Associates, Inc.: Product Portfolio
Table 70 W. L. Gore & Associates, Inc.: Key Developments
LIST OF FIGURES
Figure 1 Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 4 Global Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 6 Global Peripheral Interventions Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Peripheral Interventions Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Stents Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 9 Angioplasty Balloons Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 10 Catheters & Sheaths Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 11 Guide Wires Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 12 Atherectomy Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 13 Embolic / Embolization Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 14 Thrombectomy Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 15 Inferior Vena Cava (IVC) Filters Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 16 Other Devices & Accessories Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Peripheral Interventions Market Y-o-Y Growth, By Intervention Type, 2023-2033 (%)
Figure 18 Atherectomy Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 19 Stent Implantation Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 20 Angioplasty Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 21 Thrombectomy Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 22 Embolization Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Peripheral Interventions Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 24 Peripheral Artery Disease Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 25 Venous Thromboembolism Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 26 Others Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Peripheral Interventions Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 28 Hospitals End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 29 ASCs End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 30 Cath Labs/Specialty Clinics End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 31 Other End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 32 Global Peripheral Interventions Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 33 North America Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 34 North America Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 North America Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 36 North America Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 37 North America Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 38 North America Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 39 Asia-Pacific Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 40 Asia-Pacific Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 41 Asia-Pacific Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 42 Asia-Pacific Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 43 Asia-Pacific Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 44 Asia-Pacific Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 45 Europe Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 46 Europe Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 47 Europe Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 48 Europe Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 49 Europe Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 50 Europe Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 51 South America Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 52 South America Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 53 South America Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 54 South America Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 55 South America Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 56 South America Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 57 Middle East and Africa Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 58 Middle East and Africa Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 59 Middle East and Africa Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 60 Middle East and Africa Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 61 Middle East and Africa Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 62 Boston Scientific Corporation: Financials
Figure 63 Medtronic: Financials
Figure 64 Abbott: Financials
Figure 65 Terumo Corporation: Financials
Figure 66 Cook: Financials
Figure 67 B. Braun SE: Financials
Figure 68 BD: Financials
Figure 69 Cordis: Financials
Figure 70 Biotronik: Financials
Figure 71 W. L. Gore & Associates, Inc.: Financials
Figure 1 Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 4 Global Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 5 Global Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 6 Global Peripheral Interventions Market Share, By Region, 2024 & 2033 (%)
Figure 7 Global Peripheral Interventions Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 8 Stents Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 9 Angioplasty Balloons Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 10 Catheters & Sheaths Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 11 Guide Wires Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 12 Atherectomy Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 13 Embolic / Embolization Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 14 Thrombectomy Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 15 Inferior Vena Cava (IVC) Filters Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 16 Other Devices & Accessories Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 17 Global Peripheral Interventions Market Y-o-Y Growth, By Intervention Type, 2023-2033 (%)
Figure 18 Atherectomy Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 19 Stent Implantation Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 20 Angioplasty Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 21 Thrombectomy Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 22 Embolization Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Peripheral Interventions Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 24 Peripheral Artery Disease Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 25 Venous Thromboembolism Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 26 Others Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Peripheral Interventions Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 28 Hospitals End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 29 ASCs End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 30 Cath Labs/Specialty Clinics End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 31 Other End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 32 Global Peripheral Interventions Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 33 North America Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 34 North America Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 North America Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 36 North America Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 37 North America Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 38 North America Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 39 Asia-Pacific Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 40 Asia-Pacific Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 41 Asia-Pacific Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 42 Asia-Pacific Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 43 Asia-Pacific Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 44 Asia-Pacific Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 45 Europe Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 46 Europe Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 47 Europe Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 48 Europe Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 49 Europe Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 50 Europe Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 51 South America Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 52 South America Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 53 South America Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 54 South America Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 55 South America Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 56 South America Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)
Figure 57 Middle East and Africa Peripheral Interventions Market Value, 2022-2033 (US$ Billion)
Figure 58 Middle East and Africa Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)
Figure 59 Middle East and Africa Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)
Figure 60 Middle East and Africa Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)
Figure 61 Middle East and Africa Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)
Figure 62 Boston Scientific Corporation: Financials
Figure 63 Medtronic: Financials
Figure 64 Abbott: Financials
Figure 65 Terumo Corporation: Financials
Figure 66 Cook: Financials
Figure 67 B. Braun SE: Financials
Figure 68 BD: Financials
Figure 69 Cordis: Financials
Figure 70 Biotronik: Financials
Figure 71 W. L. Gore & Associates, Inc.: Financials
